DCGI panel to review on Friday SII applications for Covovax’s use among kids aged 2-7 yrs, 7-11 yrs
The subject expert committee on COVID-19 of India’s drug regulator will on Friday review the applications of Serum Institute of India seeking emergency use authorisation to use Covovax among those aged two to seven years and seven to 11 years, official sources said. The two applications were submitted by Prakash Kumar Singh, Director, Government and … Read more